Mark Meltz

Mark Meltz

Consigliere Generale presso LYELL IMMUNOPHARMA, INC.
52 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Mark Adam Meltz is Secretary & General Counsel at Lyell Immunopharma, Inc. since 2025.
Formerly, Mr. Meltz was COO, Secretary, Treasurer & General Counsel at Kinnate Biopharma, Inc. from 2020 to 2024; Senior Vice President & General Counsel at Astellas Gene Therapies, Inc. from 2019 to 2020; Chief Business Development & Legal Officer at Emergent Travel Health, Inc. from 2014 to 2019; Associate General Counsel at Biogen, Inc. from 2007 to 2012; Counsel at BMC Partners LLP; and Head-North & Latin America Legal Division at Novartis Vaccines & Diagnostics, Inc. Education includes undergraduate studies at Yale University and graduate studies at Boston College Law School.

Posizioni attive di Mark Meltz

SocietàPosizioneInizio
LYELL IMMUNOPHARMA, INC. Consigliere Generale 09/06/2025

Precedenti posizioni note di Mark Meltz

SocietàPosizioneFine
KINNATE BIOPHARMA INC. Direttore Finanziario/CFO 07/06/2021
AUDENTES THERAPEUTICS, INC. Consigliere Generale 01/02/2020
Consigliere Generale 01/03/2019
BIOGEN INC. Consigliere Generale 01/03/2012
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Mark Meltz

Formazione di Mark Meltz

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

65

Relazioni di 1° grado

9

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private9

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Mark Meltz